Dina N Greene1, Robert L Schmidt2, Robert H Christenson3, Jessica Rongitsch4, Katherine L Imborek5,6, Heather Rebuck3, Thomas S Lorey7, Amy K Saenger8, Matthew D Krasowski9. 1. Department of Laboratory Medicine, University of Washington, Seattle. 2. Department of Pathology, University of Utah, Salt Lake City. 3. Department of Pathology, University of Maryland, Baltimore. 4. Capitol Hill Medical, Seattle, Washington. 5. Department of Family Medicine, University of Iowa Hospitals and Clinics, Iowa City. 6. Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City. 7. Department of Laboratory Medicine, The Permanente Medical Group, Oakland, California. 8. Departments of Laboratory Medicine and Pathology at Hennepin Healthcare/Hennepin County Medical Center and University of Minnesota, Minneapolis. 9. Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City.
Abstract
Importance: Sex-specific differences in the commonly used cardiac biomarkers high-sensitivity cardiac troponin (hs-cTn) and N-terminal pro-brain natriuretic peptide (NT-proBNP) are apparent. There is an absence of medical literature delineating the concentration differences for these biomarkers in transgender individuals without cardiac disease. Objective: To determine the distribution of hs-cTn and NT-proBNP in healthy transgender people. Design, Setting, and Participants: In this cross-sectional prospective study, healthy transgender individuals prescribed testosterone or estradiol for 12 months or more were recruited from internal medicine and primary care clinics that specialize in transgender medical care between November 1, 2017, and July 1, 2018. Exposures: Testosterone or estradiol for 12 months. Main Outcomes and Measures: Concentrations for hs-cTnI (troponin I), hs-cTnT (troponin T), and NT-proBNP were measured. Results: Transgender people prescribed testosterone (n = 79; mean [SD] age, 28.8 [7.8] years) or estrogen (n = 93; mean [SD] age, 35.1 [11.7] years) were recruited. The concentration of hs-cTn was significantly higher in transgender men relative to transgender women. For Abbott hs-cTnI levels, the median (IQR) concentration observed in transgender men and women was 0.9 (0.6-1.7) ng/L and 0.6 (0.3-1.0) ng/L, respectively. Results were similar across 2 additional hs-cTn assays. In contrast, NT-proBNP level was higher in transgender women. The median (IQR) NT-proBNP concentration was significantly higher in transgender women ( 49 [32-86] ng/L) than in transgender men (17 [13-27] ng/L). Conclusions and Relevance: Findings of this cross-sectional study suggest that the differences in concentration for hs-cTn and NT-proBNP between transgender men and women were similar to what is observed between cisgender men and women. Sex hormones, rather than sex assigned at birth, may be a stronger driver of the observed concentration differences between healthy men and women for biomarkers of cardiac disease.
Importance: Sex-specific differences in the commonly used cardiac biomarkers high-sensitivity cardiac troponin (hs-cTn) and N-terminal pro-brain natriuretic peptide (NT-proBNP) are apparent. There is an absence of medical literature delineating the concentration differences for these biomarkers in transgender individuals without cardiac disease. Objective: To determine the distribution of hs-cTn and NT-proBNP in healthy transgender people. Design, Setting, and Participants: In this cross-sectional prospective study, healthy transgender individuals prescribed testosterone or estradiol for 12 months or more were recruited from internal medicine and primary care clinics that specialize in transgender medical care between November 1, 2017, and July 1, 2018. Exposures: Testosterone or estradiol for 12 months. Main Outcomes and Measures: Concentrations for hs-cTnI (troponin I), hs-cTnT (troponin T), and NT-proBNP were measured. Results: Transgender people prescribed testosterone (n = 79; mean [SD] age, 28.8 [7.8] years) or estrogen (n = 93; mean [SD] age, 35.1 [11.7] years) were recruited. The concentration of hs-cTn was significantly higher in transgender men relative to transgender women. For Abbott hs-cTnI levels, the median (IQR) concentration observed in transgender men and women was 0.9 (0.6-1.7) ng/L and 0.6 (0.3-1.0) ng/L, respectively. Results were similar across 2 additional hs-cTn assays. In contrast, NT-proBNP level was higher in transgender women. The median (IQR) NT-proBNP concentration was significantly higher in transgender women ( 49 [32-86] ng/L) than in transgender men (17 [13-27] ng/L). Conclusions and Relevance: Findings of this cross-sectional study suggest that the differences in concentration for hs-cTn and NT-proBNP between transgender men and women were similar to what is observed between cisgender men and women. Sex hormones, rather than sex assigned at birth, may be a stronger driver of the observed concentration differences between healthy men and women for biomarkers of cardiac disease.
Authors: Dorien M Kimenai; Emma B N J Janssen; Kai M Eggers; Bertil Lindahl; Hester M den Ruijter; Otto Bekers; Yolande Appelman; Steven J R Meex Journal: Clin Chem Date: 2018-05-29 Impact factor: 8.327
Authors: Alan H B Wu; Robert H Christenson; Dina N Greene; Allan S Jaffe; Peter A Kavsak; Jordi Ordonez-Llanos; Fred S Apple Journal: Clin Chem Date: 2018-01-17 Impact factor: 8.327
Authors: Michael G Fradley; Martin G Larson; Susan Cheng; Elizabeth McCabe; Erin Coglianese; Ravi V Shah; Daniel Levy; Ramachandran S Vasan; Thomas J Wang Journal: Am J Cardiol Date: 2011-08-23 Impact factor: 2.778
Authors: Dina N Greene; Gabrielle Winston McPherson; Jessica Rongitsch; Katherine L Imborek; Robert L Schmidt; Robert M Humble; Nicole Nisly; Nancy J Dole; Susan K Dane; Janice Frerichs; Matthew D Krasowski Journal: Clin Chim Acta Date: 2019-02-13 Impact factor: 3.786
Authors: Robert M Humble; Dina N Greene; Robert L Schmidt; Gabrielle Winston McPherson; Jessica Rongitsch; Katherine L Imborek; Nicole Nisly; Nancy J Dole; Susan K Dane; Janice Frerichs; Matthew D Krasowski Journal: J Appl Lab Med Date: 2022-09-01
Authors: Carl G Streed; Lauren B Beach; Billy A Caceres; Nadia L Dowshen; Kerrie L Moreau; Monica Mukherjee; Tonia Poteat; Asa Radix; Sari L Reisner; Vineeta Singh Journal: Circulation Date: 2021-07-08 Impact factor: 39.918
Authors: Dorien M Kimenai; Anoop S V Shah; David A McAllister; Kuan Ken Lee; Athanasios Tsanas; Steven J R Meex; David J Porteous; Caroline Hayward; Archie Campbell; Naveed Sattar; Nicholas L Mills; Paul Welsh Journal: Clin Chem Date: 2021-10-01 Impact factor: 12.167